Clinical trial
A Randomized, Double-blind, Placebo Controlled, Exploratory Study to Assess the Safety and Efficacy of Multiple Doses of ACZ885 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00581945 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo Controlled, Exploratory Study to Assess the Safety and Efficacy of Multiple Doses of ACZ885 in Chronic Obstructive Pulmonary Disease (COPD) Patients
- Lead sponsor
- Novartis
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- May 31, 2010
- Enrollment
- 147 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease